You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,292,935


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,292,935 protect, and when does it expire?

Patent 10,292,935 protects CREXONT and is included in one NDA.

This patent has twenty-five patent family members in twelve countries.

Summary for Patent: 10,292,935
Title:Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
Abstract:The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric coated polymer; and (b) a decarboxylase inhibitor component.
Inventor(s):Hsu Ann, Dong Liang C., Ding Amy, Gupta Suneel
Assignee:Impax Laboratories, Inc.
Application Number:US15092086
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,292,935: A Detailed Analysis

Introduction

Patent 10,292,935, like any other patent, is a complex document that outlines the scope and claims of an invention. To analyze this patent, it is crucial to understand the patent's context, the claims it makes, and how it fits into the broader patent landscape.

Patent Overview

Patent Number and Title

The United States Patent 10,292,935 is a specific patent that has been granted by the USPTO. The title of the patent provides the first clue about its subject matter.

Inventors and Assignees

Identifying the inventors and assignees can give insights into the origins and ownership of the patent. This information is typically found in the patent document's header.

Filing and Grant Dates

The filing date and grant date are important for understanding the timeline of the patent's development and its current status.

Claims Analysis

Independent and Dependent Claims

Patent claims are divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Language and Scope

The language used in the claims is critical. Longer independent claims and a higher count of independent claims can indicate a broader patent scope, although this is not always the case. Narrower claims, on the other hand, may be associated with a higher probability of grant and a shorter examination process[3].

Examples from Recent Guidance

The 2024 USPTO guidance update on AI patent eligibility provides valuable insights into how claims should be crafted. For instance, claims must integrate a judicial exception into a practical application to be considered patent-eligible. This involves assessing whether the claim imposes meaningful limits on the exception, transforming it into patent-eligible subject matter[1].

Patent Scope and Eligibility

Subject Matter Eligibility

The patent's subject matter must be eligible under 35 U.S.C. ยง 101. The recent USPTO guidance emphasizes the importance of evaluating whether a claim integrates a judicial exception into a practical application. This ensures that the claimed invention offers a concrete technological improvement[1].

Practical Applications

Claims that merely use abstract ideas or mathematical models without applying them in a specific manner are generally not patent-eligible. However, claims that specify the use of the invention in a real-world application, such as improving speech recognition systems, can meet the criteria for patent eligibility[1].

Prior Art and Search Strategies

Conducting a Preliminary Search

To understand the patent landscape, it is essential to conduct a thorough search for prior art. The USPTO provides several tools, including the Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs), to help in this process[4].

International Search Resources

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can also reveal relevant prior art and help in assessing the novelty of the invention[4].

Patent Landscape and Competition

Patent Family and Citations

Analyzing the patent family and citations can provide insights into the invention's impact and its place within the broader technological landscape. Tools like the Global Dossier and Common Citation Document (CCD) can help in this analysis[4].

Market and Technological Trends

Understanding the market and technological trends related to the patent can help in assessing its commercial viability and potential for innovation. This involves looking at industry reports, research papers, and expert opinions.

Legal and Regulatory Considerations

Recent Case Law and Guidance

The 2024 USPTO guidance update incorporates recent Federal Circuit decisions, ensuring that the application of patent eligibility criteria is consistent and reflects the latest judicial thinking. This is crucial for navigating the legal landscape surrounding the patent[1].

Potential for Small Claims Courts

The discussion around establishing a small claims patent court, as studied by ACUS, could impact how disputes related to this patent are handled in the future. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes[2].

Key Takeaways

  • Claims Craftsmanship: The patent's claims must be carefully crafted to integrate judicial exceptions into practical applications to ensure patent eligibility.
  • Prior Art Search: Thorough searches using USPTO and international resources are essential for understanding the patent's novelty and scope.
  • Legal Compliance: The patent must comply with recent guidance and case law to maintain its validity.
  • Market Context: Understanding the market and technological trends is vital for assessing the patent's commercial viability.
  • Regulatory Environment: Changes in the regulatory environment, such as the potential for small claims courts, could impact how patent disputes are resolved.

FAQs

What is the significance of the 2024 USPTO guidance update on AI patent eligibility?

The 2024 USPTO guidance update clarifies the process for determining the patent eligibility of AI-related inventions, emphasizing the integration of judicial exceptions into practical applications and providing new examples to guide practitioners[1].

How do I conduct a thorough search for prior art related to a patent?

You can use tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases such as those from the EPO, JPO, and WIPO to conduct a thorough search for prior art[4].

What are the key elements of patent claims that ensure patent eligibility?

Claims must integrate a judicial exception into a practical application, impose meaningful limits on the exception, and demonstrate a concrete technological improvement to be considered patent-eligible[1].

How does the potential for a small claims patent court impact patent disputes?

A small claims patent court could provide a more streamlined and cost-effective way to resolve patent disputes, making it easier for smaller entities to protect their intellectual property[2].

What metrics can be used to measure patent scope?

Metrics such as independent claim length and independent claim count can be used to measure patent scope, with narrower claims often associated with a higher probability of grant and a shorter examination process[3].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent Small Claims Court - ACUS
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO - USPTO
  5. 2024 Guidance Update on Patent Subject Matter Eligibility - Federal Register

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,292,935

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Impax CREXONT carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 217186-001 Aug 7, 2024 RX Yes No 10,292,935 ⤷  Subscribe Y TREATMENT OF PARKINSON'S DISEASE ⤷  Subscribe
Impax CREXONT carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 217186-002 Aug 7, 2024 RX Yes No 10,292,935 ⤷  Subscribe Y TREATMENT OF PARKINSON'S DISEASE ⤷  Subscribe
Impax CREXONT carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 217186-003 Aug 7, 2024 RX Yes No 10,292,935 ⤷  Subscribe Y TREATMENT OF PARKINSON'S DISEASE ⤷  Subscribe
Impax CREXONT carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 217186-004 Aug 7, 2024 RX Yes Yes 10,292,935 ⤷  Subscribe Y TREATMENT OF PARKINSON'S DISEASE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.